REGULATION OF TUMOR NECROSIS FACTOR-ALPHA TRANSCRIPTION IN MACROPHAGES - INVOLVEMENT OF 4 KAPPA-B-LIKE MOTIFS AND OF CONSTITUTIVE AND INDUCIBLE FORMS OF NF-KAPPA-B

被引:887
作者
COLLART, MA [1 ]
BAEUERLE, P [1 ]
VASSALLI, P [1 ]
机构
[1] LUDWIG MAXIMILIANS UNIV,GENZENTRUM,W-8033 MARTINSRIED,GERMANY
关键词
D O I
10.1128/MCB.10.4.1498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1498 / 1506
页数:9
相关论文
共 40 条
[1]   ACTIVATION OF DNA-BINDING ACTIVITY IN AN APPARENTLY CYTOPLASMIC PRECURSOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
CELL, 1988, 53 (02) :211-217
[2]   A 65-KD SUBUNIT OF ACTIVE NF-KAPPA-B IS REQUIRED FOR INHIBITION OF NF-KAPPA-B BY I-KAPPA-B [J].
BAEUERLE, PA ;
BALTIMORE, D .
GENES & DEVELOPMENT, 1989, 3 (11) :1689-1698
[3]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[4]   2 TRANSCRIPTION FACTORS, NF-KAPPA-B AND H2TF1, INTERACT WITH A SINGLE REGULATORY SEQUENCE IN THE CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX PROMOTER [J].
BALDWIN, AS ;
SHARP, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) :723-727
[5]   THE HISTORY, PROPERTIES, AND BIOLOGICAL EFFECTS OF CACHECTIN [J].
BEUTLER, B ;
CERAMI, A .
BIOCHEMISTRY, 1988, 27 (20) :7575-7582
[6]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[7]   NF-KAPPA-B BINDS WITHIN A REGION REQUIRED FOR B-CELL-SPECIFIC EXPRESSION OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENE E-ALPHA-D [J].
BLANAR, MA ;
BURKLY, LC ;
FLAVELL, RA .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :844-846
[8]   THE SAME INDUCIBLE NUCLEAR PROTEINS REGULATES MITOGEN ACTIVATION OF BOTH THE INTERLEUKIN-2 RECEPTOR-ALPHA GENE AND TYPE-1 HIV [J].
BOHNLEIN, E ;
LOWENTHAL, JW ;
SIEKEVITZ, M ;
BALLARD, DW ;
FRANZA, BR ;
GREENE, WC .
CELL, 1988, 53 (05) :827-836
[9]  
COLLART MA, 1989, ONCOGENE, V4, P237
[10]  
COLLART MA, 1987, J IMMUNOL, V139, P949